<DOC>
	<DOCNO>NCT01664117</DOCNO>
	<brief_summary>This observational multicenter study evaluate management disease safety clinical practice patient moderate severe rheumatoid arthritis receive biological therapy monotherapy .</brief_summary>
	<brief_title>An Observational Study Clinical Practice Management Patients With Biological Drugs Monotherapy</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Adult patient , &gt; /=18 year age Patients moderate severe rheumatoid arthritis inadequate response intolerance disease modify antirheumatic drug ( DMARDs ) biological drug Patients treat biologic DMARDs alone least 6 month Patients willing unable give write informed consent participation study Patients participate clinical trial time study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>